Sponsored By

2023’s Biggest Medtech Losers

From regulatory and merger struggles to recalls and lessening demand for specific products, these companies are ready to say goodbye to a difficult 2023.

Katie Hobbins

November 27, 2023

7 Slides

2023 is coming to a close and some companies are welcoming the opportunity of a fresh start in 2024 after regulatory and merger struggles, recalls, and lessening demand for specific products.

However, before we can move on to the prospects of new beginnings, let’s take a look back at the biggest losers of the year and why they’ve snatched a place this list.

About the Author(s)

Katie Hobbins

Managing Editor, MD+DI

Katie Hobbins is managing editor for MD+DI and joined the team in July 2022. She boasts multiple previous editorial roles in print and multimedia medical journalism, including dermatology, medical aesthetics, and pediatric medicine. She graduated from Cleveland State University in 2018 with a bachelor's degree in journalism and promotional communications. She enjoys yoga, hand embroidery, and anything DIY. You can reach her at [email protected].

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like